Iambic Therapeutics

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Genesis Therapeutics is an AI platform that leverages cutting-edge technology to revolutionize drug discovery and development processes. The platform integrates advanced algorithms and machine learning models to accelerate the identification of novel drug candidates and optimize their properties. By combining computational simulations with experimental data, Genesis Therapeutics offers a comprehensive solution to streamline the drug development pipeline and bring innovative therapies to market faster. The platform is designed to empower researchers and pharmaceutical companies with powerful tools for predicting drug-target interactions, optimizing molecular structures, and prioritizing lead compounds for further investigation.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Vidon.ai is an AI-powered application that offers a range of innovative features to enhance user experience. The platform leverages artificial intelligence technology to provide users with personalized recommendations, real-time insights, and predictive analytics. With Vidon.ai, users can streamline their decision-making processes, optimize workflows, and unlock new opportunities for growth and efficiency. The application is designed to be user-friendly and intuitive, making it accessible to a wide range of users across different industries.

fal.ai is a generative media platform designed for developers to build the next generation of creativity. It offers lightning-fast inference with no compromise on quality, providing access to high-quality generative media models optimized by the fal Inference Engine™. The platform allows developers to fine-tune their own models, leverage real-time infrastructure for new user experiences, and scale to thousands of GPUs as needed. With a focus on developer experience, fal.ai aims to be the fastest AI tool for running diffusion models.

Personno.ai is an AI-driven market research platform that provides businesses with access to a pool of AI-generated respondents. These respondents are designed to mimic the behavior and characteristics of real human respondents, allowing businesses to conduct research studies quickly and cost-effectively. Personno.ai's platform includes a range of features that make it easy to create and manage research studies, including the ability to create custom audiences, conduct real-time interviews, and collect both qualitative and quantitative data.

Raman Labs is an AI tool that offers dedicated modules for computer vision-based tasks. It allows users to integrate machine learning functionality into their existing applications with just 2 lines of code, ensuring real-time performance even with high-resolution data on consumer-grade CPUs. The tool provides a clean and minimalistic API for easy integration, robust to large scale and resolution variations, versatile to run on various platforms, and adaptive to scale with the computing power of the system.

Loata is an AI-powered platform that serves as a learning orchestrator for adaptive text analyses. It allows users to store their notes and documents in the cloud, which are then ingested and transformed into knowledge bases. The platform features smart AI agents powered by LLMs to provide intelligent answers based on the content. With end-to-end encryption and controlled ingestion, Loata ensures the security and privacy of user data. Users can choose from different subscription plans to access varying levels of storage and query capacity, making it suitable for individuals and professionals alike.

Vectorize is a fast, accurate, and production-ready AI tool that helps users turn unstructured data into optimized vector search indexes. It leverages Large Language Models (LLMs) to create copilots and enhance customer experiences by extracting natural language from various sources. With built-in support for top AI platforms and a variety of embedding models and chunking strategies, Vectorize enables users to deploy real-time vector pipelines for accurate search results. The tool also offers out-of-the-box connectors to popular knowledge repositories and collaboration platforms, making it easy to transform knowledge into AI-generated content.

Fathom5 is a company that specializes in the intersection of AI and industrial systems. They offer a range of products and services to help customers build more resilient, flexible, and efficient industrial systems. Fathom5's approach is unique in that they take a security-first approach to cyber-physical system design. This means that security is built into every stage of the development process, from ideation to engineering to testing to deployment. This approach has been proven to achieve higher system resiliency and faster regulatory compliance at a reduced cost.

Lily AI is an e-commerce product discovery platform that helps brands increase sales and improve customer experience. It uses artificial intelligence to understand the language of customers and inject it across the retail ecosystem, from search to recommendations to demand forecasting. Lily AI's platform is purpose-built for retail and turns qualitative product attributes into a universal, customer-centered mathematical language with unprecedented accuracy. This results in a depth and scale of attribution that no other solution can match.

SmartEq.ai is an AI-driven platform that revolutionizes the development of groundbreaking technology products through innovative approaches. The platform leverages cutting-edge AI tools like Nostradamus for market research and equity distribution, empowering end users to shape and own the products. SmartEq.ai also offers a unique equity crowdfunding platform, saaseq.app, to democratize access to early-stage investment opportunities. By fostering a collaborative and rewarding ecosystem, SmartEq.ai is redefining the traditional boundaries between SaaS startups and users, driving innovation in the tech industry.

STELLARWITS is an AI solutions and software platform that empowers users to explore cutting-edge technology and innovation. The platform offers AI models with versatile capabilities, ranging from content generation to data analysis to problem-solving. Users can engage directly with the technology, experiencing its power in real-time. With a focus on transforming ideas into technology, STELLARWITS provides tailored solutions in software and AI development, delivering intelligent systems and machine learning models for innovative and efficient solutions. The platform also features a download hub with a curated selection of solutions to enhance the digital experience. Through blogs and company information, users can delve deeper into the narrative of STELLARWITS, exploring its mission, vision, and commitment to reshaping the tech landscape.

Arro is an AI-powered research assistant that helps product teams collect customer insights at scale. It uses automated conversations to conduct user interviews with thousands of customers simultaneously, generating product opportunities that can be directly integrated into the product roadmap. Arro's innovative AI-led methodology combines the depth of user interviews with the speed and scale of surveys, enabling product teams to gain a comprehensive understanding of their customers' needs and preferences.

LangChain is an AI tool that offers a suite of products supporting developers in the LLM application lifecycle. It provides a framework to construct LLM-powered apps easily, visibility into app performance, and a turnkey solution for serving APIs. LangChain enables developers to build context-aware, reasoning applications and future-proof their applications by incorporating vendor optionality. LangSmith, a part of LangChain, helps teams improve accuracy and performance, iterate faster, and ship new AI features efficiently. The tool is designed to drive operational efficiency, increase discovery & personalization, and deliver premium products that generate revenue.

TradeBX is an AI-powered trading platform that provides advanced AI algorithms, an inbuilt training course, and a user-friendly interface. Its AI algorithms analyze vast amounts of data in real-time to identify profitable opportunities and execute trades with precision. The platform also offers a training course to help users leverage the bot's advanced features and strategies. With 24/7 trading and a user-friendly interface, TradeBX empowers traders of all levels to achieve their financial goals.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Comparables.ai is an AI-powered company and market intelligence platform designed for M&A professionals. It offers comprehensive data insights, valuation multiples, and market analysis to help users make informed decisions in investment banking, private equity, and corporate finance. The platform leverages AI technology to provide relevant company information, financial data, and M&A transaction history, enabling users to identify new investment targets, benchmark companies, and conduct market analysis efficiently.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Manifold is an AI data platform designed specifically for life sciences. It offers a collaborative workbench, data science tools, AI-powered cohort exploration, batch bioinformatics, data dashboards, data engineering solutions, access control, and more. The platform aims to enable faster collaboration and research in the life sciences field by providing a comprehensive suite of tools and features. Trusted by leading institutions, Manifold helps streamline data collection, analysis, and collaboration to accelerate scientific research.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Rationale is a cutting-edge decision-making tool powered by advanced AI technology, including the latest GPT model and in-context learning capabilities. It leverages artificial intelligence to provide users with valuable insights and recommendations for making informed decisions across various domains.

Mnemonic AI is an advanced Customer Intelligence tool that offers AI Personas and Digital Twin of the Customer. It helps organizations improve their understanding of individuals by creating data-driven buyer personas and virtual customers. The tool analyzes OCEAN Big Five Personality Traits and Schwartz Universal Values to tailor messages and marketing strategies. Mnemonic AI automates the process of creating personas and updating customer data, providing deep insights for informed decision-making.

functime is a time-series machine learning tool designed to perform forecasting at scale. It provides functions for scoring, ranking, and plotting thousands of forecasts simultaneously. With a focus on guiding users through their first end-to-end forecasting pipeline, functime serves as an AI copilot to analyze trends, seasonality, and causal factors in forecasts. The tool offers a comprehensive API reference and documentation, making it a valuable resource for both beginners and experienced analysts.

Kolank is an AI platform offering a unified API with agent interoperability, automatic model selection, and cost optimization. It enables AI agents to communicate and collaborate efficiently, providing access to a wide range of AI models for text, image, and video processing. With features like load balancing, fallbacks, and performance metrics, Kolank simplifies AI model integration and usage, making it a comprehensive solution for various AI tasks.

Promptmakr is a platform designed for buying and selling AI prompts. It serves as a marketplace where users can find and offer AI prompts for various purposes. The platform aims to connect individuals and businesses looking for AI prompts with those who create and sell them. With a user-friendly interface, Promptmakr simplifies the process of discovering, purchasing, and selling AI prompts, making it a convenient solution for both buyers and sellers in the AI industry.

StockGPT is an AI-powered financial research assistant that provides knowledge of earnings releases, financial reports, and fundamental information for S&P 500 and Nasdaq companies. It offers features like AI-powered search, customizable filters, up-to-date data, and industry research to help users analyze companies and markets more efficiently.

XenonStack is an AI application that offers a comprehensive suite of tools and services for building and managing Agentic Systems. The platform provides solutions for data management, analytics, AI transformation, and decision-making processes. With features like AI-enabled catalogs, industrial automation, and agent orchestration, XenonStack aims to empower enterprises to reimagine their business workflows and drive efficiency and agility through intelligent AI agents.

Unlearn.ai is an AI-driven platform that specializes in streamlining clinical trials through the use of AI-generated digital twins of patients. By leveraging digital twin technology and disease-specific ML models, Unlearn.ai enables researchers to design and run more efficient and impactful clinical trials across various therapeutic areas. The platform offers solutions to accelerate trial timelines, facilitate faster decision-making, and optimize trial design, ultimately enhancing trial efficiency, insights, and impact.